HUMAN STEM CELLS INSTITUTE PJSC

human-stem-cells-institute-pjsc-logo

Human Stem Cell Institute (PJSC "HSCI") - a Russian public company founded in 2003 and works in the field of modern biomedical technology and health care. HSCI develops and implements in medical practice (commercialization and promotion of the market), innovative medicines, as well as high-tech medical services.

#SimilarOrganizations #People #Financial #Website #More

HUMAN STEM CELLS INSTITUTE PJSC

Social Links:

Industry:
Biotechnology

Founded:
2003-01-01

Address:
Moscow, Moscow City, Russian Federation

Country:
Russian Federation

Website Url:
http://www.hsci.ru

Total Employee:
101+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt WordPress Domain Not Resolving Apache Wordpress Plugins


Similar Organizations

amarna-therapeutics-logo

Amarna Therapeutics

Amarna Therapeutics is a privately held European biotechnology company.

not_available_image

Pantheco

Pantheco operates as a biotech company.

Founder


artur-isaev_image

Artur Isaev

Investments List

Date Company Article Money raised
2021-01-01 Histograft Human stem cells institute PJSC investment in Seed Round - Histograft 509 K USD

Official Site Inspections

http://www.hsci.ru

  • Host name: fe.shared.masterhost.ru
  • IP address: 90.156.201.12
  • Location: Russia
  • Latitude: 55.7386
  • Longitude: 37.6068
  • Timezone: Europe/Moscow

Loading ...

More informations about "Human stem cells institute PJSC"

Human Stem Cells Institute - Craft

Human Stem Cells Institute is a biomedical technologies and healthcare solutions provider. It develops and implements medicines, neovasculgen, gemabank, reprobank, genetico, prenetix, …See details»

Human stem cells institute PJSC - Crunchbase

Contact Email [email protected]; Phone Number +7 (495) 646-80-76; Human Stem Cell Institute (PJSC "HSCI") - a Russian public company founded in 2003 and works in the field of …See details»

HSCI changed its name to Artgen Biotech and presented a new …

On July 18, 2023, Human Stem Cell Institute (HSCI, MOEX: ISKJ) announced that it was renamed Artgen Biotech. At the official presentation, the company showed its new corporate …See details»

Medvestnik: HSCI changed its name and rebranded - en.artgen.ru

The decision to change the name was approved in the end of June. The goal of the rebranding is to make the company’s activities, strategy, and values more understandable to a wide range of …See details»

Human Stem Cells Institute Information - RocketReach

Human Stem Cells Institute (HSCI) is a Russian public biotech company founded in 2003. HSCI is engaged in drug discovery, R&D and marketing of innovative proprietary products and …See details»

Human Stem Cells Institute - LinkedIn

Human Stem Cells Institute | 326 followers on LinkedIn. Human Stem Cells Institute (HSCI) is a Russian public biotech company founded in 2003. HSCI is engaged in drug discovery, R&D and marketing ...See details»

Human Stem Cells Institute OJSC - Business Information - ZoomInfo

View Human Stem Cells Institute OJSC (www.hsci.ru) location in Russian Federation , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»

Company Human Stem Cells Institute - MarketScreener.com

Jan 4, 2004 Institut Stvolovykh Kletok Cheloveka PAO (Human Stem Cells Institute OJSC or HSCI OJSC) is a Russia-based company engaged in the research and development, as well …See details»

Human Stem Cells Institute – StemCell Therapy

Jul 6, 2018 Human Stem Cells Institute PJSC (HSCI) is a Russian public biotech company founded in 2003. HSCI is engaged in drug discovery, R&D and marketing of innovative …See details»

Company Human Stem Cells Institute OTC Markets

Jan 4, 2004 Institut Stvolovykh Kletok Cheloveka PAO (Human Stem Cells Institute OJSC or HSCI OJSC) is a Russia-based company engaged in the research and development, as well …See details»

Open Joint-Stock Company Human Stem Cells Institute

Human Stem Cells Institute PJSC (HSCI, MOEX: ISKJ) is a Russian public biotech company founded in 2003. Overview Structured Data Issues Contributors Activity. Contents. hsci.ru. Is …See details»

Human Stem Cells Institute PJSC (Russia) (Q4201743) - wikidata.org

Language Label Description Also known as; English: Human Stem Cells Institute PJSC (Russia) company in Moscow, RussiaSee details»

Human Stem Cells Institute - Alchetron, the free social encyclopedia

Jan 22, 2024 Human Stem Cells Institute OJSC (HSCI) ( or ) is a Russian public biotech company founded in 2003. HSCI engages in RD as well as commercialization and marketing …See details»

Head of the Department of Regenerative Medicine - LinkedIn

Human Stem Cells Institute (OJSC "HSCI") is a Russian public biotech company founded in 2003. Main directions of HSCI activity include development, commercialization, and marketing of …See details»

An HSCI company became a resident of the Lomonosov Cluster

Nextgen, a biotech company of the Human Stem Cell Institute group (HSCI, MOEX: ISKJ), became a resident of the Lomonosov Cluster of the Vorobyovy Gory MSU Innovative …See details»

HSCI and Its Management Buy Out a Share of GENETICO from the …

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Нежелательная (побочная) реакция Отсутствие …See details»

JSC Human Stem Cell Institute Announces IPO Price Range for …

Oct 7, 2009 On September 23, 2009 HSCI won the “Promising Business” award and was granted a Golden Certificate at the 10th Russian Venture Fair. More information about HSCI is …See details»

INSTITUT : HSCI’s Innovative Neovasculgen® Drug Included into …

Moscow, 11 January 2016. PJSC HSCI - The Human Stem Cells Institute ('HSCI', MOEX: ISKJ), one of Russia's leading biotech companies, today announced that its innovative drug …See details»

Gene Therapy for PAD Approved - Research & Development World

Dec 7, 2011 The Human Stem Cells Institute has received state approval for Neovasculgen – the first Russian gene-therapy drug to treat peripheral arterial disease. The drug’s international …See details»

Institutional Profile: Harvard Stem Cell Institute

May 10, 2010 In 2004, Harvard University (MA, USA) created the Harvard Stem Cell Institute (HSCI), an organization that spans the University‘s schools and its affiliated hospitals, as the …See details»

linkstock.net © 2022. All rights reserved